JP2005323968A - Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument - Google Patents

Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument Download PDF

Info

Publication number
JP2005323968A
JP2005323968A JP2004171890A JP2004171890A JP2005323968A JP 2005323968 A JP2005323968 A JP 2005323968A JP 2004171890 A JP2004171890 A JP 2004171890A JP 2004171890 A JP2004171890 A JP 2004171890A JP 2005323968 A JP2005323968 A JP 2005323968A
Authority
JP
Japan
Prior art keywords
cancer
membrane
viral
instrument
treatment instrument
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004171890A
Other languages
Japanese (ja)
Inventor
Yuko Take
ゆう子 武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2004171890A priority Critical patent/JP2005323968A/en
Publication of JP2005323968A publication Critical patent/JP2005323968A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To eliminate a need for an operation on cancer, to avoid a side effect and to completely cure the cancer, viral/bacterial infectious diseases. <P>SOLUTION: This treatment instrument internally cures an affected site by passing through blood vessels and does not require an operation. Furthermore, as the instrument destroys only cells having an abnormal DNA or RNA, it does not destroy normal cells and does not cause a side effect. The instrument passes through blood vessels in the whole body and can cure no matter where cancerous cells, viruses or bacteria are. The instrument can cure the cancer even if the cancer has transferred to somewhere. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、医学の分野に属する発明である。本発明は大きさ、形状、性質を赤血球と同様に造ったものである。膜骨格上に、異常なDNA又はRNAを感知するセンサーと、細胞膜や核膜、細胞壁、ウイルスの殻を貫き、核酸分解酵素を注入する管を取り付けた装置である。本発明は、生理的食塩水に混ぜ、点滴方式で静脈から体内に入れて使用する。  The present invention belongs to the medical field. The present invention has the same size, shape and properties as those of red blood cells. This is a device in which a sensor that senses abnormal DNA or RNA and a tube that penetrates the cell membrane, nuclear membrane, cell wall, and virus shell and injects a nucleolytic enzyme are attached on the membrane skeleton. The present invention is mixed with physiological saline and used by instilling into the body from a vein.

本発明は、新しい技術を利用した発明であり、比較する技術は存在していない。  The present invention uses a new technology, and there is no technology for comparison.

癌にかかっても、手術を行なわなくても良いようにする。また、副作用が出ないものにする。そして、癌やウイルス・細菌感染症を完全に治療できるようにする。  Try not to have surgery if you have cancer. Also, make sure there are no side effects. And to be able to completely treat cancer and viral / bacterial infections.

本発明は、血管を通り体内から患部を治していくので、手術を行う必要がない。さらに、異常なDNA又はRNAをもつものしか破壊しないので、正常な細胞を破壊することがなく、副作用が出ない。本発明は、全身の血管を通るので、癌細胞やウイルス、細菌がどこに存在していても治療できる。さらに、癌においては転移があっても治療できる。  In the present invention, since the affected part is cured from the body through the blood vessel, it is not necessary to perform an operation. Furthermore, since only those having abnormal DNA or RNA are destroyed, normal cells are not destroyed, and no side effects occur. Since the present invention passes through blood vessels throughout the body, it can be treated where cancer cells, viruses, and bacteria are present. Furthermore, cancer can be treated even if there is metastasis.

本発明により、上記に示したような効果が得られる。  According to the present invention, the effects as described above can be obtained.

本装置の直径は7μm、厚さは2μmであり、膜骨格や膜、管は分子レベルでの製造になるため、原子を見られる顕微鏡を用いての作業になる。膜骨格は、装置がパラシュート型や砲弾型に変形し、毛細血管を通過できるようにする。センサーと管は、装置に納まる大きさとし、管はできるだけ細くし、細菌が持つ細胞壁やウイルスが持つ殻を貫けるほど硬いもので、伸ばせるようにする。そして、白血球に外敵と見なされないようにするために膜の表面に血液型物質を付ける。素材は、膜骨格、膜は赤血球と同様で、センサー、管、管台は体内で無害な物質に分解されるものとする。管は、膜が壊される時に一緒に壊されるようにする。  This device has a diameter of 7 μm and a thickness of 2 μm. Since the membrane skeleton, membrane, and tube are manufactured at the molecular level, the operation is performed using a microscope that can see atoms. The membrane skeleton allows the device to be transformed into a parachute type or a shell type so that it can pass through capillaries. The sensor and tube should be sized to fit in the device, and the tube should be as thin as possible, so that it will be hard enough to penetrate the cell walls of bacteria and the shell of viruses, and be stretchable. Then, a blood type substance is attached to the surface of the membrane so that the white blood cells are not regarded as foreign enemies. The material is the membrane skeleton, the membrane is the same as red blood cells, and the sensor, tube, and nozzle are broken down into harmless substances in the body. The tubes are broken together when the membrane is broken.

初めに、別々に膜骨格、センサー、管を造る。次に、膜骨格上に管台、管、センサーを取り付ける。そして、核酸分解酵素を入れ、膜で覆う。最後に、血液型物質を膜上に付ける。  First, build the membrane skeleton, sensor, and tube separately. Next, a nozzle, a tube, and a sensor are attached on the membrane skeleton. Then, nuclease is put and covered with a membrane. Finally, a blood group substance is applied on the membrane.

上から見た図である。It is the figure seen from the top. 装置の断面図である。It is sectional drawing of an apparatus. 装置の管が癌細胞に入りこんだ図である。FIG. 3 is a view of a device tube entering a cancer cell.

符号の説明Explanation of symbols

1 センサー
2 管
3 膜骨格
4 管台
1 sensor 2 tube 3 membrane skeleton 4 nozzle stand

Claims (4)

大きさ、形状、性質を赤血球と同様に造り、白血球に外敵と見なされないようにした装置。  A device that has the same size, shape, and properties as red blood cells, so that white blood cells are not considered foreign enemies. 装置の内部に核酸分解酵素を入れたもの。  A device in which a nucleolytic enzyme is placed inside the device. 膜骨格上に異常なDNA又はRNAを感知するセンサーを取り付けた装置。  A device with a sensor that detects abnormal DNA or RNA on the membrane skeleton. 膜骨格上に、スライド式で細胞膜や核膜、細菌が持つ細胞壁、ウイルスが持つ殻を貫き、核内に酵素を注入するための管を取り付けた装置。  A device that slides through the cell membrane and nuclear membrane, the cell wall of bacteria, and the shell of the virus on the membrane skeleton, and a tube for injecting the enzyme into the nucleus.
JP2004171890A 2004-05-14 2004-05-14 Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument Pending JP2005323968A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004171890A JP2005323968A (en) 2004-05-14 2004-05-14 Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004171890A JP2005323968A (en) 2004-05-14 2004-05-14 Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument

Publications (1)

Publication Number Publication Date
JP2005323968A true JP2005323968A (en) 2005-11-24

Family

ID=35470771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004171890A Pending JP2005323968A (en) 2004-05-14 2004-05-14 Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument

Country Status (1)

Country Link
JP (1) JP2005323968A (en)

Similar Documents

Publication Publication Date Title
Zeng et al. Super‐mini percutaneous nephrolithotomy (SMP): a new concept in technique and instrumentation
VILLÁNYI et al. Short-term changes in renal function after extracorporeal shock wave lithotripsy in children
JP7466594B2 (en) Systems and devices for administering substances
CN102698354A (en) Double-sacculus conduit for thrombolysis
CN106265679A (en) Bromine domain protein inhibitor is preparing the purposes that anti-HIV-1 is hidden in medicine
Zubor et al. Cold atmospheric pressure plasma (CAP) as a new tool for the management of vulva cancer and vulvar premalignant lesions in gynaecological oncology
Zhang et al. Ultrasound‐microbubble cavitation facilitates adeno‐associated virus mediated cochlear gene transfection across the round‐window membrane
Yang et al. Neuroinflammation of microglia polarization in intracerebral hemorrhage and its potential targets for intervention
CN202620464U (en) Ozone and ultrasonic combined gynecology treatment device
CN104667439A (en) Focusing ultrasonic treatment head and ultrasonic treatment equipment
JP2005323968A (en) Erythrocytic type cancer, viral/bacterial infectious disease treatment instrument
CN112912127A (en) Tethered ultrasound devices and uses thereof
CN102697631A (en) Ozone and ultrasonic combined gynecological treatment device
KR102232757B1 (en) Delivery device of target material using extracorporeal shock wave
CN108578693A (en) Photochemical method for preparation for the autologous plasma inactivated vaccine for treating AIDS
CN109498809A (en) One kind containing nanometer gold bar-curing agent and preparation method for vascular malformation treatment
CN103170023A (en) AIDS therapeutic equipment and manufacturing method
CN101912306A (en) Device for rercutaneous interventional minimally-invasive treatment of tuberculosis focus in vivo
CA2298041A1 (en) Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery
Zheng et al. COMPARATIVE ANALYSIS OF GENE TRANSFER TO HUMAN AND RAT RETINAL PIGMENT EPITHELIUM CELL LINE BY A COMBINATORIA! USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS AND ULTRASOUND OR/AND MICROBUBBLES
CN105687203B (en) Applications of the cholecystokinin receptor inhibitor Devazepide in anti-fibrosis medicine preparation is prepared
Tarar A Review on Key Modulatory Novel Features, Viral Assembly, Biomarkers Associated with Biological Replication and Molecular Genetics in Progression of Coronaviruses
CN206229822U (en) A kind of Dispoable medical consumptive material automatic loading and unloading and destruction system
Miller et al. Plasma Dose for Clinical Applications: New Considerations
Taneja Re: Nanoparticle-Enabled Selective Destruction of Prostate Tumor Using MRI-Guided Focal Photothermal Therapy

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061020

A131 Notification of reasons for refusal

Effective date: 20061114

Free format text: JAPANESE INTERMEDIATE CODE: A131

A02 Decision of refusal

Effective date: 20070410

Free format text: JAPANESE INTERMEDIATE CODE: A02